CHRS - Coherus BioSciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.29B
Enterprise Value 31.38B
Trailing P/E N/A
Forward P/E 1-266.43
PEG Ratio (5 yr expected) 1-0.96
Price/Sales (ttm)34.87
Price/Book (mrq)N/A
Enterprise Value/Revenue 337.27
Enterprise Value/EBITDA 6-8.03

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-472.05%

Management Effectiveness

Return on Assets (ttm)-69.59%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)37.1M
Revenue Per Share (ttm)0.55
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-106.38M
EBITDA -172.12M
Net Income Avi to Common (ttm)-185.05M
Diluted EPS (ttm)-2.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)96.43M
Total Cash Per Share (mrq)1.39
Total Debt (mrq)185.3M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.84
Book Value Per Share (mrq)-0.56

Cash Flow Statement

Operating Cash Flow (ttm)-182.66M
Levered Free Cash Flow (ttm)-111.43M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.37
52-Week Change 319.67%
S&P500 52-Week Change 34.25%
52 Week High 321.18
52 Week Low 38.32
50-Day Moving Average 317.88
200-Day Moving Average 314.05

Share Statistics

Avg Vol (3 month) 3900.28k
Avg Vol (10 day) 3691.59k
Shares Outstanding 569.37M
Float 59.26M
% Held by Insiders 13.54%
% Held by Institutions 197.45%
Shares Short (May 31, 2019) 46.94M
Short Ratio (May 31, 2019) 47.02
Short % of Float (May 31, 2019) 411.70%
Short % of Shares Outstanding (May 31, 2019) 410.00%
Shares Short (prior month Apr 30, 2019) 47.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A